Normal Expression of a Rearranged and Mutated c- myc Oncogene After Transfection into Fibroblasts
Authors:
- 27 October 1989
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 246 (4929) , 494-497
Abstract
Expression of the c-myc oncogene is deregulated in a variety of malignancies. Rearrangement and mutation of the c-myc locus is a characteristic feature of human Burkitt's lymphoma. Whether deregulation is solely a result of mutation of c-myc or whether it is influenced by the transformed B cell context has not been determined. A translocated and mutated allele of c-myc was stably transfected into fibroblasts. The rearranged allele was expressed indistinguishably from a normal c-myc gene: it had serum-regulated expression, was transcribed with normal promoter preference, and was strongly attenuated. Thus mutations by themselves are insufficient to deregulate c-myc transcription.Keywords
This publication has 30 references indexed in Scilit:
- A transcriptional repressor of c-mycNature, 1989
- A human immunoglobulin gene reduces the incidence of lymphomas in c-Myc-bearing transgenic miceNature, 1988
- c-myc gene regulation still holds its secretTrends in Genetics, 1987
- Mutations in the First Exon Are Associated with Altered Transcription of c- myc in Burkitt LymphomaScience, 1987
- A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cellsNature, 1986
- The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic miceNature, 1985
- Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogeneNature, 1984
- Effect of somatic mutation within translocated c-myc genes in Burkitt's lymphomaNature, 1984
- A novel alteration in the structure of an activated c-myc gene in a variant t(2;8) burkitt lymphomaCell, 1984
- Activation of a translocated human c-myc gene by an enhancer in the immunoglobulin heavy-chain locusNature, 1984